Acute effects of acetazolamide on cerebral blood flow in man.

We have followed the time course of the effect of the carbonic anhydrase inhibitor acetazolamide injected i.v. in unanesthetized healthy human beings. The dose administered was 500 mg as a bolus. Cerebral blood flow (CBF) was measured continuously before, during and after the injection, using a pulsed ultrasound doppler system, which measured the instantaneous mean velocity across the lumen of the internal carotid artery, just below its entrance into the skull. Ventilation, heart-rate, end-expiratory PCO2, arterial PCO2, pH and systemic blood pressure was also measured. We found that acetazolamide caused a rise in CBF which could be detected as early as 2 min after the injection. A maximal average response of 75% increase in CBF was seen after 25 min. The half-time of the declining phase of the response was 95 min. There were no systematic differences in the CO2 reactivities, given as delta CBF/delta PACO2 in % of CBF at normocapnia, before and after acetazolamide injection, regardless of the absolute PACO2 level. The present dose of the drug caused no change in ventilation, alveolar and arterial PCO2 or in arterial blood pH indicating that the carbonic anhydrase was not fully inhibited. Our observations show that acetazolamide nevertheless caused a rapid vasodilation in the brain and over a wide range of PCO2's. We suggest that this agent has a local vasodilator effect on the cerebral arterioles, unrelated to its specific effects as a carbonic anhydrase inhibitor.

[1]  P. Wistrand.  The importance of carbonic anhydrase B and C for the unloading of CO2 by the human erythrocyte. , 1981, Acta physiologica Scandinavica.

[2]  L. Walløe,et al.  Changes in cerebral blood flow during hyperventilation and CO2-breathing measured transcutaneously in humans by a bidirectional, pulsed, ultrasound Doppler blood velocitymeter. , 1980, Acta physiologica Scandinavica.

[3]  L. Holder,et al.  Diffusion of sulfonamides in aqueous buffers and into red cells. , 1965, Molecular Pharmacology.

[4]  P. Curtis.  Letter: Medicine by remote control. , 1973, Lancet.

[5]  P. Hackett,et al.  THE INCIDENCE, IMPORTANCE, AND PROPHYLAXIS OF ACUTE MOUNTAIN SICKNESS , 1976, The Lancet.

[6]  L. Walløe,et al.  Blood flow in arteries determined transcutaneously by an ultrasonic doppler velocitymeter as compared to electromagnetic measurements on the exposed vesels. , 1980, Acta physiologica Scandinavica.

[7]  S. Cotev,et al.  Role of Cerebrospinal Fluid pH In Management of Respiratory Problems , 1969, Anesthesia and analgesia.

[8]  L. J. Roth,et al.  Sulfur-35 labeled acetazolamide in cat brain. , 1959, The Journal of pharmacology and experimental therapeutics.

[9]  E. Linnér,et al.  THE INITIAL DROP OF THE INTRAOCULAR PRESSURE FOLLOWING INTRAVENOUS ADMINISTRATION OF ACETAZOLAMIDE IN MAN , 1959, Acta ophthalmologica.

[10]  T. Maren,et al.  The pharmacology of methazolamide in relation to the treatment of glaucoma. , 1977, Investigative ophthalmology & visual science.

[11]  J. Astrup,et al.  Brain carbonic acid acidosis after acetazolamide. , 1975, Acta physiologica Scandinavica.

[12]  D L EHRENREICH,et al.  Influence of acetazolamide on cerebral blood flow. , 1961, Archives of neurology.

[13]  M. Raichle,et al.  The effect of acetazolamide on cerebral blood flow and oxygen utilization in the rhesus monkey. , 1978, The Journal of clinical investigation.

[14]  B. Lehmann,et al.  The Pharmacokinetics of Acetazolamide in Relation to its Use in the Treatment of Glaucoma and to its Effects as an Inhibitor of Carbonic Anhydrases , 1970 .

[15]  O. Paulson,et al.  Carbon dioxide permeability of the blood-brain barrier in man. The effect of acetazolamide. , 1980, Microvascular research.

[16]  T. Maren,et al.  A quantitative analysis of CO2 transport at rest and during maximal exercise. , 1978, Respiration physiology.

[17]  S Wille,et al.  A computer system for on-line decoding of ultrasonic Doppler signals from blood flow measurement. , 1977, Ultrasonics.

[18]  F. Plum,et al.  The toxic effects of carbon dioxide and acetazolamide in hepatic encephalopathy. , 1960, The Journal of clinical investigation.

[19]  M. Brightman,et al.  Transport of proteins across normal cerebral arterioles , 1973, The Journal of comparative neurology.

[20]  Hanson Ma,et al.  The location of carbonic anhydrase in relation to the blood-brain barrier at the medullary chemoreceptors of the cat. , 1981 .

[21]  S. Cotev,et al.  The Effect of Ventilation and Acetazolamide (Diamox) on Cerebral Blood Flow in Chronic Respiratory Acidosis , 1968 .

[22]  S. Cotev,et al.  The effects of acetazolamide on cerebral blood flow and cerebral tissue PO2. , 1968, Anesthesiology.

[23]  A. Otis,et al.  Carbon dioxide transport in anesthetized dogs during inhibition of carbonic anhydrase. , 1961, Journal of applied physiology.

[24]  M. Landowne,et al.  Effect of acetazolamide on acute mountain sickness. , 1968, The New England journal of medicine.

[25]  Y. Shinohara.  Mechanism of chemical control of cerebral vasomotor activity , 1973, Neurology.

[26]  J. Meyer,et al.  Interaction of cerebral hemodynamics and metabolism , 1961, Neurology.

[27]  D. Rall,et al.  Preferential vasoconstrictor properties of acetazolamide on the arteries of the choroid plexus. , 1966, International journal of neuropharmacology.